These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Early appearance of complement-dependent antibody mediated cytotoxicity (C'AMC) to islet cells in serum of diabetes-prone BB/OK rats.
    Author: Hehmke B, Schröder D, Klöting I.
    Journal: Diabetes Res; 1990 Apr; 13(4):183-6. PubMed ID: 2134210.
    Abstract:
    The present study examines the ability of serum from BB rats below the age of 33 days to mediate cytotoxicity to islet cells in vitro. Serum activities of complement-dependent antibody mediated cytotoxicity (C'AMC) were cross-sectionally analyzed in diabetes-prone BB/OK rats at 10 (n = 14), 20 (n = 14) and 30 (n = 10) days of age and were compared with those in non-diabetic, diabetes-prone BB/OK rats studied at 50 (n = 10) and 100 (n = 10) days of age. Exposure of 51Cr-labeled neonatal rat islet cells to sera from diabetes-prone BB/OK rats and rabbit complement revealed C'AMC activities above the mean + 2 SD of that of control Wistar rats in only two (14%) cases at day 10. This percentage increased to 79% at day 20 with all animals being C'AMC-positive at day 30. The means of the specific 51Cr-release were 3.6 +/- 1.7% at day 10, 10.4 +/- 2.2% at day 20, and 16.1 +/- 1.8% at day 30. Also, 90% of BB/OK rats investigated at 50 or 100 days of age were C'AMC-positive. In contrast, when 51Cr-labeled splenic lymphocytes were substituted for islet cells, isotope release did not exceed spontaneous release with any of the serum samples tested. Taken together, the present findings indicate that anti-islet but not anti-lymphocyte serum C'AMC activity usually appears in diabetes-prone BB/OK rats after day 10 with all animals being affected at day 30. The absence of cytolytic activity in 86% of BB/OK rats studied at 10 days of age strongly suggests, however, that anti-islet C'AMC is neither an inborn abnormality of humoral immunity in the BB rat nor does it seem to be passively acquired by transplacental passage.
    [Abstract] [Full Text] [Related] [New Search]